Floatz logo

Clozapine

Clozapine

Ruijin HospitalSmall moleculeEarly Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Clozapine cohort.

Asset / SponsorPhaseRating
Semaglutide
Anders Fink-Jensen, MD, DMSci
Phase 4BB
Suo Quan Wan
Taichung Veterans General Hospital
Phase 2CCC

Same molecule, other indications

Clozapine is also rated in:

Psychotic DisorderDormant
BBB
Indicative ·
78 / 100
View asset →
Dual DiagnosisDormant
BB
Indicative ·
70 / 100
View asset →
schizophreniaDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →